Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D08RYN
|
||||
Former ID |
DIB015184
|
||||
Drug Name |
RQ-00202730
|
||||
Synonyms |
Cannabinoid CB2 agonists (IBS/IBD, oral), RaQualia
|
||||
Indication | Inflammatory bowel disease [ICD9: 555, 556; ICD10:K50, K51] | Investigative | [543878] | ||
Company |
RaQualia Pharma Inc
|
||||
Target and Pathway | |||||
Target(s) | Cannabinoid receptor 2 | Target Info | Agonist | [543878] | |
KEGG Pathway | Neuroactive ligand-receptor interaction | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.